Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
49.82
+1.06 (2.17%)
At close: Jul 2, 2026, 4:00 PM EDT
49.97
+0.15 (0.30%)
After-hours: Jul 2, 2026, 5:36 PM EDT
Enliven Therapeutics Employees
Enliven Therapeutics had 61 employees as of March 31, 2026. The number of employees decreased by 4 or -6.15% compared to the same quarter last year.
Employees
61
Change
-4
Growth
-6.15%
Revenue / Employee
n/a
Profits / Employee
-$1,619,295
Market Cap
3.48B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 61 | -4 | -6.15% |
| Dec 31, 2025 | 60 | -2 | -3.23% |
| Sep 30, 2025 | 65 | 8 | 14.04% |
| Jun 30, 2025 | 63 | 11 | 21.15% |
| Mar 31, 2025 | 65 | 15 | 30.00% |
| Dec 31, 2024 | 62 | 16 | 34.78% |
| Sep 30, 2024 | 57 | 13 | 29.55% |
| Jun 30, 2024 | 52 | 15 | 40.54% |
| Mar 31, 2024 | 50 | 21 | 72.41% |
| Dec 31, 2023 | 46 | 17 | 58.62% |
| Sep 30, 2023 | 44 | 20 | 83.33% |
| Jun 30, 2023 | 37 | 13 | 54.17% |
| Mar 31, 2023 | 29 | - | - |
| Sep 30, 2022 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| Celldex Therapeutics | 198 |
ELVN News
- 3 days ago - Enliven price target raised to $80 from $60 at Stifel - TheFly
- 6 days ago - Enliven price target raised to $70 from $45 at JonesResearch - TheFly
- 19 days ago - Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 22 days ago - Why Is Enliven Therapeutics Stock (ELVN) Up Today? - TipRanks
- 22 days ago - Enliven rises 9.9% - TheFly
- 23 days ago - Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants - PRNewsWire
- 23 days ago - Enliven announces $250M common stock offering - TheFly
- 23 days ago - Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - PRNewsWire